These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30549029)

  • 1. Rapamycin enhances growth inhibition on urothelial carcinoma cells through LKB1 deficiency-mediated mitochondrial dysregulation.
    Whang YM; Kim MJ; Cho MJ; Yoon H; Choi YW; Kim TH; Chang IH
    J Cell Physiol; 2019 Aug; 234(8):13083-13096. PubMed ID: 30549029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of NBR1 in urothelial carcinoma cells enhances rapamycin-induced apoptosis through impaired autophagy and mitochondrial dysfunction.
    Kim MJ; Hwang GY; Cho MJ; Chi BH; Park SI; Chang IH; Whang YM
    J Cell Biochem; 2019 Nov; 120(11):19186-19201. PubMed ID: 31297862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.
    Makhlin I; Zhang J; Long CJ; Devarajan K; Zhou Y; Klein-Szanto AJ; Huang M; Chernoff J; Boorjian SA
    BJU Int; 2011 Jul; 108(2 Pt 2):E84-90. PubMed ID: 21050361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.
    Whang YM; Park SI; Trenary IA; Egnatchik RA; Fessel JP; Kaufman JM; Carbone DP; Young JD
    Oncogene; 2016 Feb; 35(7):856-66. PubMed ID: 26119936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells.
    Li F; Yang C; Zhang HB; Ma J; Jia J; Tang X; Zeng J; Chong T; Wang X; He D; Guo P
    Cancer Med; 2019 Aug; 8(10):4792-4805. PubMed ID: 31250978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation.
    Shen YQ; Guerra-Librero A; Fernandez-Gil BI; Florido J; García-López S; Martinez-Ruiz L; Mendivil-Perez M; Soto-Mercado V; Acuña-Castroviejo D; Ortega-Arellano H; Carriel V; Diaz-Casado ME; Reiter RJ; Rusanova I; Nieto A; López LC; Escames G
    J Pineal Res; 2018 Apr; 64(3):. PubMed ID: 29247557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.
    Hansel DE; Platt E; Orloff M; Harwalker J; Sethu S; Hicks JL; De Marzo A; Steinle RE; Hsi ED; Theodorescu D; Ching CB; Eng C
    Am J Pathol; 2010 Jun; 176(6):3062-72. PubMed ID: 20395440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence.
    Kim SJ; Kim JH; Jung HS; Lee TJ; Lee KM; Chang IH
    Asian J Androl; 2014; 16(4):611-7. PubMed ID: 24625880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rictor-dependent AKT activation and inhibition of urothelial carcinoma by rapamycin.
    Wu MJ; Chang CH; Chiu YT; Wen MC; Shu KH; Li JR; Chiu KY; Chen YT
    Urol Oncol; 2012; 30(1):69-77. PubMed ID: 20207175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells.
    Gordeev SA; Bykova TV; Zubova SG; Bystrova OA; Martynova MG; Pospelov VA; Pospelova TV
    Oncotarget; 2015 Dec; 6(42):44905-26. PubMed ID: 26636543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone (T
    Yau WW; Singh BK; Lesmana R; Zhou J; Sinha RA; Wong KA; Wu Y; Bay BH; Sugii S; Sun L; Yen PM
    Autophagy; 2019 Jan; 15(1):131-150. PubMed ID: 30209975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.
    Chung SJ; Nagaraju GP; Nagalingam A; Muniraj N; Kuppusamy P; Walker A; Woo J; Győrffy B; Gabrielson E; Saxena NK; Sharma D
    Autophagy; 2017 Aug; 13(8):1386-1403. PubMed ID: 28696138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
    Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
    Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
    Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
    Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
    PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells.
    Ma L; Niknejad N; Gorn-Hondermann I; Dayekh K; Dimitroulakos J
    PLoS One; 2012; 7(9):e46055. PubMed ID: 23029387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galangin inhibits proliferation of HepG2 cells by activating AMPK via increasing the AMP/TAN ratio in a LKB1-independent manner.
    Zhang H; Li N; Wu J; Su L; Chen X; Lin B; Luo H
    Eur J Pharmacol; 2013 Oct; 718(1-3):235-44. PubMed ID: 24028940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.